Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms.

Heymans, Stephane; Cooper, Leslie T

Heymans, Stephane; Cooper, Leslie T.

Heymans S; Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, Netherlands. s.heymans@maastrichtuniversity.nl.
Cooper LT; Department of Cardiovascular Medicine, Mayo Clinic in Florida, Jacksonville, FL, USA.

Nat Rev Cardiol ; 19(2): 75-77, 2022 02.

Article in English | MEDLINE | ID: covidwho-1565720

Subject(s)

COVID-19 Vaccines; Myocarditis; Vaccines, Synthetic; mRNA Vaccines; COVID-19 Vaccines/administration & dosage; COVID-19 Vaccines/adverse effects; Humans; Myocarditis/epidemiology; Vaccines, Synthetic/administration & dosage; Vaccines, Synthetic/adverse effects; mRNA Vaccines/administration & dosage; mRNA Vaccines/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Synthetic / COVID-19 Vaccines / MRNA Vaccines / Myocarditis Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Nat Rev Cardiol Journal subject: Cardiology Year: 2022 Document Type: Article Affiliation country: S41569-021-00662-w

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google